About deucravac itinib
TYK2 inhibitor
Used for
- Moderate to severe plaque psoriasis in adults who may benefit from systemic treatment or phototherapy.
- Active psoriatic arthritis in adults.
Usual adult dose
6 mg by mouth once daily for plaque psoriasis or psoriatic arthritis.
Common side effects
- Upper respiratory infections
- Raised creatine phosphokinase
- Herpes simplex infections
- Mouth ulcers
Important warnings
- Check for tuberculosis before treatment; treat active tuberculosis first.
- Avoid live vaccines during treatment.
- Serious infections can occur; treatment may need to stop during severe infection.
- Monitor for liver problems, especially with existing liver disease.
Pregnancy
Human pregnancy information is limited; use only if the potential benefit justifies possible fetal risk.
Breastfeeding
It is unknown whether deucravacitinib passes into breast milk; effects on a nursing infant are unknown.
Interactions
- Avoid strong CYP1A2 inhibitors, which may increase drug levels.
- Avoid live vaccines during treatment.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.